Or Filter by:

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA

1-877-ELANCO1

(1-877-352-6261)

Media Contacts

Questions?
Contact us.



Our Global Offices

Follow Elanco

18-SEPT-2019

Elanco Celebrates IPO Anniversary with Recommitment to Customer Advocacy, Centering on the Power of Healthy Animals

Post by: Colleen Parr Dekker

Healthy animals are the game-changing variable that will unlock solutions for some of the world’s biggest challenges

GREENFIELD, Ind., (September 18, 2019) - Elanco Animal Health (NYSE: ELAN) today publicly marked the first anniversary of its IPO on September 20, 2018 and transformation into an independent public company. In the past year, Elanco has advanced its innovation, portfolio and productivity (IPP) strategy designed to broaden our portfolio and pipeline to bring new solutions to farmers, veterinarians and pet owners.

“As we celebrate Elanco’s first anniversary as a fully independent, dedicated animal health company, we’re fulfilling the promises made during our IPO to customers,” said Jeff Simmons, president and chief executive officer of Elanco. “In my 30 years in this business, animal health and agriculture have never been more relevant or had more opportunity to impact our customers and society at large.”

As a dedicated animal health company, Elanco has strengthened its customer focus and advocacy efforts in two ways: delivering innovation and portfolios for customers that meet their challenges; and, elevating the public conversation on the critical role healthy animals play in the health of people and the planet.

Over the past year, the company added new innovation to its pipeline in the areas of vaccines, enzymes and companion animal therapeutics. Additionally, Elanco’s most recent announcement to acquire Bayer AG’s animal health business strengthens and accelerates the company’s proven IPP strategy. Elanco’s strong focus on greater speed, agility, and ability to allocate its investments, have helped customers face their toughest challenges.

Elanco also established Elanco’s Healthy PurposeTM, its corporate social responsibility (CSR) framework, advancing the well-being of animals, people, and the planet and enabling the company to realize its vision of Food and Companionship Enriching Life. It underscores the company’s belief that healthy animals are key to solving some of the world’s most pressing issues, such as food security and nutrition, human health and well-being, and environmental sustainability.

As a central part of Elanco’s commitment to addressing these issues, the company has launched a call to rediscover the power of healthy animals. The effort is designed to put the importance of helping animals lead healthier lives front and center in critical conversations about food and nutrition security, human emotional and physical well-being and the sustainability of our planet.

Simmons said, “Our business is built on the belief that that animals are the x-factor society has been looking for – the unexpected, game-changing variable that we believe will unlock solutions to seemingly disconnected issues. Healthier animals, from cats to cows, are pivotal to our mental health, physical health and the health of our planet. It’s time we rediscovered and leaned into the benefits of pets and protein on a healthy lifestyle.”

To learn more, listen to the Rediscovering the Power of Healthy Animals podcast, and access additional resources at www.elanco.com/rediscovered.

ABOUT ELANCO
Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 65-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life - all to advance the health of animals, people and the planet. Learn more at www.elanco.com.

Media Contact:
Colleen Parr Dekker
(317) 989-7011
colleen_parr_dekker@elanco.com

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA

1-877-ELANCO1

(1-877-352-6261)

Media Contacts

Questions?
Contact us.



Our Global Offices

Follow Elanco

About Elanco

Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.